These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36579974)

  • 21. Persistence of urgency and urge urinary incontinence in women with mixed urinary symptoms after midurethral slings: a multivariate analysis.
    Lee JK; Dwyer PL; Rosamilia A; Lim YN; Polyakov A; Stav K
    BJOG; 2011 Jun; 118(7):798-805. PubMed ID: 21392244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overactive bladder symptoms after midurethral sling surgery in women: Risk factors and management.
    Marcelissen T; Van Kerrebroeck P
    Neurourol Urodyn; 2018 Jan; 37(1):83-88. PubMed ID: 28631830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic impact of using fesoterodine for the treatment of overactive bladder with urge urinary incontinence in a vulnerable elderly population in the United States.
    Qin L; Luo X; Zou KH; Snedecor SJ
    J Med Econ; 2016; 19(3):229-35. PubMed ID: 26488196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overactive Bladder Patients With and Without Urgency Incontinence: A Spectrum of One Condition or Different Phenotypes?
    Torosis M; Jackson N; Nitti V; Ackerman AL
    Urogynecology (Phila); 2023 Jan; 29(1):33-40. PubMed ID: 36548103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
    Martin-Garcia M; Crampton J
    Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship Between Central Obesity, General Obesity, Overactive Bladder Syndrome and Urinary Incontinence Among Male and Female Patients Seeking Care for Their Lower Urinary Tract Symptoms.
    Lai HH; Helmuth ME; Smith AR; Wiseman JB; Gillespie BW; Kirkali Z;
    Urology; 2019 Jan; 123():34-43. PubMed ID: 30393054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overactive bladder and urgency urinary incontinence in men undergoing artificial urinary sphincter placement.
    Jahromi MS; Engle K; Furlong D; Guevara Méndez A; Gomez CS
    Neurourol Urodyn; 2020 Jun; 39(5):1489-1493. PubMed ID: 32339308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mirabegron for overactive bladder syndrome.
    Drug Ther Bull; 2013 Aug; 51(8):90-2. PubMed ID: 23949821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.
    Coyne KS; Sexton CC; Kopp ZS; Ebel-Bitoun C; Milsom I; Chapple C
    BJU Int; 2011 Nov; 108(9):1459-71. PubMed ID: 21371240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does urinary urgency drive urinary frequency in overactive bladder?
    Versi E; Rovner ES; Dmochowski RR; Tu LM; De Wachter S
    Low Urin Tract Symptoms; 2022 Jul; 14(4):242-247. PubMed ID: 35233968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does symptom severity predict response to low-dose onabotulinumtoxinA for the treatment of urgency urinary incontinence?
    Gonzalez HM; Wheat JE; Dengler KL; Barbier HM; Gehrich AP; Gruber DD; Warner WB
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():118-124. PubMed ID: 33212321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of transobturator tape on overactive bladder symptoms and urge urinary incontinence in women with mixed urinary incontinence.
    Tahseen S; Reid P
    Obstet Gynecol; 2009 Mar; 113(3):617-623. PubMed ID: 19300325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary Biomarkers in Women with Refractory Urgency Urinary Incontinence Randomized to Sacral Neuromodulation versus OnabotulinumtoxinA Compared to Controls.
    Richter HE; Moalli P; Amundsen CL; Malykhina AP; Wallace D; Rogers R; Myers D; Paraiso M; Albo M; Shi H; Nolen T; Meikle S; Word RA;
    J Urol; 2017 Jun; 197(6):1487-1495. PubMed ID: 28089729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.
    Ginsberg D; Schneider T; Kelleher C; Van Kerrebroeck P; Swift S; Creanga D; Martire DL
    BJU Int; 2013 Aug; 112(3):373-85. PubMed ID: 23826844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials.
    DuBeau CE; Morrow JD; Kraus SR; Creanga D; Bavendam T
    Neurourol Urodyn; 2012 Nov; 31(8):1258-65. PubMed ID: 22907761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of vibegron, a novel β3-adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo-controlled, double-blind, comparative phase 3 study.
    Yoshida M; Takeda M; Gotoh M; Yokoyama O; Kakizaki H; Takahashi S; Masumori N; Nagai S; Minemura K
    BJU Int; 2020 May; 125(5):709-717. PubMed ID: 31991511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
    Garely AD; Lucente V; Vapnek J; Smith N
    Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bothersome lower urinary tract symptoms 1 year after first delivery: prevalence and the effect of childbirth.
    van Brummen HJ; Bruinse HW; van de Pol G; Heintz AP; van der Vaart CH
    BJU Int; 2006 Jul; 98(1):89-95. PubMed ID: 16831150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fesoterodine in patients with overactive bladder syndrome: can the severity of baseline urgency urinary incontinence predict dosing requirement?
    Cardozo L; Khullar V; Wang JT; Guan Z; Sand PK
    BJU Int; 2010 Sep; 106(6):816-21. PubMed ID: 20151972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.